SAM
ELV icon

Strategy Asset Managers’s Elevance Health ELV Stock Holding History

Strategy Asset Managers’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,232
Closed -$2.42M – 260
2025
Q2 		$2.42M Buy
6,232
+374
+6% +$150K 0.45% 54
2025
Q1 		$2.55M Buy
5,858
+118
+2% +$47.4K 0.53% 53
2024
Q4 		$2.12M Sell
5,740
-1,203
-17% -$503K 0.41% 57
2024
Q3 		$3.61M Sell
6,943
-2,020
-23% -$1.08M 0.69% 44
2024
Q2 		$3.98M Buy
8,963
+2,446
+38% +$1.29M 0.88% 36
2024
Q1 		$3.38M Buy
6,517
+163
+3% +$81.1K 0.72% 42
2023
Q4 		$3M Buy
6,354
+331
+5% +$153K 0.71% 39
2023
Q3 		$2.62M Sell
6,023
-2,940
-33% -$1.33M 0.69% 41
2023
Q2 		$3.98M Buy
8,963
+1,243
+16% +$573K 0.88% 36
2023
Q1 		$3.55M Buy
7,720
+2,361
+44% +$1.12M 0.87% 37
2022
Q4 		$2.75M Sell
5,359
-36
-0.7% -$18.3K 0.7% 38
2022
Q3 		$2.45M Buy
5,395
+105
+2% +$50.2K 0.67% 44
2022
Q2 		$2.55M Buy
5,290
+176
+3% +$87.1K 0.79% 39
2022
Q1 		$2.51M Buy
5,114
+1,505
+42% +$688K 0.54% 51
2021
Q4 		$1.67M Sell
3,609
-254
-7% -$107K 0.43% 50
2021
Q3 		$1.44M Buy
3,863
+275
+8% +$105K 0.32% 66
2021
Q2 		$1.37M Buy
+3,588
New +$1.37M 0.29% 69
2018
Q3 		– Sell
-11,197
Closed -$2.67M – 146
2018
Q2 		$2.67M Sell
11,197
-430
-4% -$99.6K 0.56% 57
2018
Q1 		$2.55M Buy
+11,627
New +$2.73M 0.55% 61
2016
Q1 		– Sell
-20,378
Closed -$2.84M – 148
2015
Q4 		$2.84M Buy
20,378
+104
+0.5% +$14.3K 0.65% 48
2015
Q3 		$2.84M Sell
20,274
-56
-0.3% -$8.42K 0.68% 41
2015
Q2 		$3.34M Sell
20,330
-164
-0.8% -$26.2K 0.74% 38
2015
Q1 		$3.16M Buy
+20,494
New +$2.92M 0.69% 44

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Strategy Asset Managers's ELV Position: Q3 2025 in Review

Strategy Asset Managers sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 6,232 shares — an estimated $2.42M sold.

Strategy Asset Managers first reported a position in ELV in Q1 2015 and held it in 23 quarters. The position peaked at $3.98M in Q2 2024. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Strategy Asset Managers reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Strategy Asset Managers sold 6,232 Elevance Health shares in Q3 2025, an estimated $2.42M.
  • Strategy Asset Managers first reported a position in Elevance Health in Q1 2015 and held it in 23 quarters.
  • Strategy Asset Managers's Elevance Health position peaked at $3.98M in Q2 2024.
  • 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Strategy Asset Managers's 13F filing for Q3 2025, filed 4 Nov 2025.